Startup India Government of India
Extremz Biosciences Private Limited
Extremz Biosciences Private Limited - life sciences in Hubli, Karnataka, India. Directors, charges & compliance details.
Revenue · FY 2022
₹13,049
▼ 95% YoY
Net profit · FY 2022
₹11,335
Net margin 86.9%
EBITDA · FY 2022
₹11,335
EBITDA margin 86.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Last financials
Mar 2022
Balance sheet date
About Extremz Biosciences Private Limited
Data last updated:
Extremz Biosciences Private Limited was a private limited company based in Hubli, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 09 June 2017.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2017PTC103752.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Jayachandra and Umesh Kattegouda Madire.
Its last annual general meeting (AGM) was held on 24 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Hubli, Karnataka.
As per the financials filed for FY 2022, the company reported a revenue of ₹13,049, a decline of 95% compared to the previous year. For the same year it recorded a net profit of ₹11,335 (net margin 86.9%) and EBITDA of ₹11,335 (EBITDA margin 86.9%). Revenue has declined at a compounded annual rate (CAGR) of 74% over three years.
Company details
CIN U73200KA2017PTC103752
Registration Number 103752
Incorporation Date 09 June 2017
ROC Bangalore
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 24 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Extremz Biosciences
Contact details
Extremz Biosciences Private Limited's registered office is in Hubli, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressFirst Floor Centre For Material Science Bvb College Of Engineering & Tech Vidya, Nagar, Hubli, Karnataka, India – 580031
- IndustryLife Sciences, Biotechnology
To see the full contact details of Extremz Biosciences Private Limited, buy the company report.
Comprehensive company report
Extremz Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Extremz Biosciences Private Limited
FY 2022 filings availableExtremz Biosciences Private Limited reported revenue of ₹13,049 (down 95% YoY) for FY 2022.
Revenue · FY 2022
₹13,049 ▼ 95%
Net profit · FY 2022
₹11,335 margin 86.9%
EBITDA · FY 2022
₹11,335 margin 86.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 95%
3 years · compounded
▼ 74%
EBITDA CAGR growth
1 year
▲ 703%
3 years · compounded
▼ 30%
Revenue has declined at a compounded annual rate (CAGR) of 74% over three years, including a 95% fall in the latest year. EBITDA rose 703% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹13,049 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,335 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,335 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 86.9% | ||||
| Net Profit Margin | 86.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Extremz Biosciences Private Limited, buy the company report.
Board of directors of Extremz Biosciences Private Limited
Extremz Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Directors (as last reported)
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayachandra | Director | 09 Jun 2017 | 9 Years 4 Months | As last reported |
| Umesh Kattegouda Madire | Director | 20 Nov 2020 | 5 Years 11 Months | As last reported |
Peer comparison
Extremz Biosciences Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biosciences, Biotechnology), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Procell Biologics Private Limited | ₹14,740 (FY 2025) | -99.0% | Medchal Malkajgiri, Telangana, India | |||
| Nirmal Biosciences Private Limited | ₹14,610 (FY 2017) | -44.0% | New Delhi, Delhi, India | |||
| Council for Healthcare and Pharma Front | ₹13,829 (FY 2025) | 400.0% | New Delhi, Delhi, India | |||
| Kis Technologies (India) Private Limited | ₹13,544 (FY 2018) | Bangalore, Karnataka, India | ||||
| Mercuri Biotechnologies Private Limited | ₹13,125 (FY 2021) | -99.0% | Bangalore, Karnataka, India | |||
| Extremz Biosciences Private Limitedthis company | ₹13,049 (FY 2022) | ₹11,335 | 86.9% | -95.0% | Hubli, Karnataka, India | |
| Navya Life Sciences Research Foundation | ₹12,968 (FY 2025) | -18.0% | Hubli, Karnataka, India | |||
| Zifo Genomics Research Institute Private Limited | ₹12,630 (FY 2023) | -100.0% | Chennai, Tamil Nadu, India | |||
| Nxtbrane India Private Limited | ₹12,543 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Spectra Research and Development Private Limited | ₹11,635 (FY 2020) | -39.0% | Bhopal, Madhya Pradesh, India | |||
| Blue Leopard Genomic Essentials Private Limited | ₹10,926 (FY 2025) | -100.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Extremz Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Extremz Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Extremz Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Extremz Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Extremz Biosciences Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Sharanabasava Vishwanath Ganachari ceased to be Director on 01 Dec 2020.
AGM
Extremz Biosciences Private Limited last Annual general meeting of members was held on 24 Sep 2022 as per latest MCA records.
Filing
Extremz Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Sharanabasava Vishwanath Ganachari ceased to be Director.
Appointed
Umesh Kattegouda Madire was appointed as Director.
Appointed
Jayachandra was appointed as Director.
Incorporation
09 Jun 2017
Extremz Biosciences Private Limited was registered on 09 Jun 2017 with Roc Bangalore & aged 9 years 4 months as per MCA records.
Frequently asked questions
Extremz Biosciences has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Extremz Biosciences was a private limited company based in Hubli, Karnataka, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 09 June 2017 and is registered under CIN U73200KA2017PTC103752. The company has been struck off by the Registrar of Companies and is no longer operational.
Extremz Biosciences had 2 directors:
- Jayachandra - Director
- Umesh Kattegouda Madire - Director
The CIN (Corporate Identification Number) of Extremz Biosciences is U73200KA2017PTC103752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Extremz Biosciences is at First Floor Centre For Material Science Bvb College Of Engineering & Tech Vidya, Nagar, Hubli, Karnataka, India – 580031.
Extremz Biosciences was incorporated on 09 June 2017. It is registered with the Registrar of Companies, Bangalore.
Yes, Extremz Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The latest financial statements of Extremz Biosciences on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 24 September 2022. Year-wise statements from FY 2018 are in the company report.
Extremz Biosciences operated in the life sciences industry, in the biotechnology segment. It worked in this industry before it was struck off.
The peers of Extremz Biosciences by revenue are Procell Biologics Private Limited, Nirmal Biosciences Private Limited, Council for Healthcare and Pharma Front, Kis Technologies (India) Private Limited, Mercuri Biotechnologies Private Limited and 5 more, all in the Biotechnology industry (Biosciences, Biotechnology).
Sharanabasava Vishwanath Ganachari ceased to be Director on 01 Dec 2020. Umesh Kattegouda Madire was appointed as Director on 20 Nov 2020. Jayachandra was appointed as Director on 09 Jun 2017.